PYRIDOXINE, ISONIAZID, AND L-DOPA IN THERAPY OF PARKINSONS DISEASE

被引：0

|

作者：

FRIEDMAN, SA

机构：

来源：

AMERICAN REVIEW OF RESPIRATORY DISEASE | 1971年 / 103卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

收藏

页码：296 / &

相关论文

共 50 条

[21] 8 YEARS OF EXPERIENCE WITH L-DOPA THERAPY IN PARKINSONS DISEASE
BARBEAU, A
GILLOJOF.L
NEUROLOGY, 1969, 19 (03) : 284 - &
[22] BRADYKINESIA OF PARKINSONS DISEASE - QUANTITATIVE CHANGES WITH L-DOPA THERAPY
UTTERBAC.RA
POZOS, RS
STILES, RN
NEUROLOGY, 1971, 21 (04) : 450 - &
[23] EXCRETION OF L-DOPA AND ITS METABOLITES IN URINE OF PARKINSONS DISEASE PATIENTS RECEIVING L-DOPA THERAPY
ROUTH, JI
BANNOW, RE
FINCHAM, RW
STOLL, JL
CLINICAL CHEMISTRY, 1971, 17 (09) : 867 - +
[24] L-DOPA AND PYRIDOXINE
TRAN, N
LANCET, 1972, 11 (7766): : 45 - &
[25] ENTERIC-COATED L-DOPA (PRODOPA) - NEW APPROACH TO L-DOPA THERAPY IN PARKINSONS-DISEASE
GILLIGAN, B
HANCOCK, R
MEDICAL JOURNAL OF AUSTRALIA, 1975, 2 (22) : 824 - 826
[26] OBSERVATIONS ON PATIENTS WITH PARKINSONS DISEASE TREATED WITH L-DOPA .1. TRIAL AND EVALUATION OF L-DOPA THERAPY
VANWIERINGEN, A
WRIGHT, J
SOUTH AFRICAN MEDICAL JOURNAL, 1972, 46 (35): : 1262 - +
[27] TREATMENT OF PARKINSONS DISEASE WITH L-DOPA AND AN ASSOCIATION L-DOPA PLUS A DOPA DECARBOXYLASE INHIBITOR
FAZIO, C
BARBA, C
CASACCHIA, M
AGNOLI, A
RUGGIERI, S
VOLANTE, F
REITANO, M
ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04): : 347 - +
[28] EXCRETION OF DOPA METABOLITES IN PATIENTS WITH PARKINSONS DISEASE WHO ARE RECEIVING L-DOPA THERAPY
ROUTH, JI
CLINICAL CHEMISTRY, 1970, 16 (06) : 535 - &
[29] PARKINSONS DISEASE AND L-DOPA - PRIMARY RESULTS
WAROT, P
CHEVALIE.J
HERBAUT, G
LILLE MEDICAL, 1971, 16 (05): : 765 - &
[30] L-DOPA TREATMENT AND PARKINSONS-DISEASE
LEES, AJ
QUARTERLY JOURNAL OF MEDICINE, 1986, 59 (230): : 535 - 547

← 1 2 3 4 5 →